Countdown: Only Three Months Left! UDI Mandate Takes Effect for Class C Medical Devices in Singapore - Wiselink Group-A More Controllable, Stable, and Future-Oriented Material Direction

Home > News Center > Countdown: Only Three Months Left! UDI Mandate Takes Effect for Class C Medical Devices in Singapore

Countdown: Only Three Months Left! UDI Mandate Takes Effect for Class C Medical Devices in Singapore

Time：2026-07-31 11:05:06

Unlike markets imposing localized mandatory coding rules, Singapore’s UDI framework is fully aligned with international standards and accepts existing UDI compliance credentials from the US and EU. It stands out as a cost-efficient hub enabling "one-time UDI generation for cross-border market access". This article comprehensively unpacks the Health Sciences Authority (HSA) of Singapore’s UDI regulatory framework, implementation timeline and practical compliance tips to help manufacturers meet the critical 2026 compliance deadline.

一、Core Features of Singapore’s UDI Regulation

HSA Singapore serves as the competent authority governing the UDI system. The full rulebook strictly follows harmonization principles set by the International Medical Device Regulators Forum (IMDRF), with regulations designed to cut enterprises’ compliance costs.

（一）Direct Reuse of US & EU UDIs; No Separate Singapore-Specific Coding Required

This is the biggest advantage of Singapore’s UDI scheme: UDIs complying with US FDA or EU UDI regulations can be used directly for Singapore market circulation, with no need to apply for exclusive Singapore UDI codes. Preconditions for reuse are listed below:

The exact device model exported to Singapore must be identical to the US/EU version;
Packaging hierarchy and quantity specifications must match perfectly;
The local Singapore registration holder has updated relevant data in the Singapore Medical Device Register (SMDR).

Critical Reminder: Do NOT submit EU Basic UDI-DIs to Singapore authorities. A Basic UDI-DI is an EU-specific identifier linked to technical documentation and is never printed on product packaging. Singapore’s database requires UDI-DIs corresponding to each distinct packaging level.

（二）Risk-Based Phased Rollout; Voluntary Compliance for Low-Risk Devices

Singapore adopts a risk-tiered UDI enforcement model to reduce compliance burdens for manufacturers:

Mandatory Scope: Class B, C, D medical devices and corresponding IVD products
Voluntary Scope: Class A low-risk medical devices (no mandatory UDI obligation; manufacturers may implement UDI voluntarily)

（三）Integrated with Existing Registration Database; No Separate UDI Submission Portal

All UDI data is integrated into the Singapore Medical Device Register (SMDR). When enterprises submit registration documents via the SHARE system, UDI information will be automatically extracted from registration dossiers, labels and instructions for use. There is no standalone UDI filing portal or supplementary forms, realizing full integration of medical device registration and UDI declaration.

二、Phased Implementation Timeline

HSA rolls out UDI requirements in staggered phases with a two-year interval between risk classes. UDIs are generally not mandatory for clinical trial devices, investigational products or custom-made medical devices. Products imported via special access schemes shall follow the compliance timeline corresponding to their risk classification.

Transition Period Policy：Stock products imported into Singapore prior to the compliance cutoff date are granted a 6-month grace period for liquidation. After the transition window closes, all products on sale must fully satisfy UDI rules.

Taking Class C devices as an example:

Inventories imported before November 1, 2026 can be distributed within the subsequent six-month grace period;
All new shipments imported on or after November 1, 2026 must meet UDI requirements upon customs clearance;
Upon expiry of the transition period, non-compliant residual stocks are prohibited from further distribution in principle.

三、Breakdown of Key Compliance Mandates

（一）UDI Coding Structure Fully Aligned with Global Standards

Singapore adopts the globally recognized two-component UDI structure, consistent with EU and US regulations:

UDI-DI (Device Identifier): A fixed unique code tied to device model and packaging specifications. It acts as the primary index in the SMDR database. Updates are mandatory whenever core product attributes change, including model, specification, sterility status, etc.
UDI-PI (Production Identifier): Variable dynamic data covering batch/lot number, serial number, manufacturing date, expiry date, software version and more. It is only used for physical product traceability and does not need to be uploaded to official government databases.

（二）Mandatory Dual Carrier Labeling Requirement

Every minimum sales unit and all upper-tier packaging layers must feature two mandatory identification carriers simultaneously:

AIDC (Automatic Identification and Data Capture): 1D barcode, 2D QR code, RFID or other machine-readable formats
HRI (Human-Readable Interpretation): Full printed UDI strings legible to human inspectors

UDIs shall be affixed to all minimum supply units and every higher packaging tier as a general rule. Pure transit shipping containers are explicitly excluded from UDI labeling obligations per HSA UDI FAQs.

If surface area of the smallest package is insufficient, manufacturers shall conduct an assessment per GN-36 to optimize label layout. Original statutory label information (product name, batch number, expiry date, warning statements, etc.) cannot be removed. UDI labeling is an additional requirement and shall never replace existing mandatory label content.

（三）HSA-Authorized UDI Issuing Agencies

HSA Singapore only recognizes three global issuing bodies; manufacturers may select any one freely: GS1, HIBCC, ICCBBA.

四、Practical Compliance Recommendations for Manufacturers

Prioritize Reusing Existing Global Compliance Credentials：

Sort out the full list of your devices sold in Singapore and verify whether they already hold valid US/EU UDI certification.
For devices with compliant US/EU UDIs: Reuse the existing coding and labels directly, only verifying that your issuing body is on HSA’s approved list;
For devices without prior US/EU UDI certification: Submit applications to authorized bodies such as GS1 at the earliest and redesign product labels accordingly

Complete SMDR Data Filing in Advance：While the SHARE system supports automatic data extraction, manufacturers are advised to proactively audit UDI information in registration dossiers to ensure accurate entry of core UDI-DI data into SMDR, avoiding suspended registration status due to incomplete records.

Align Inventory Management with Supply Chain Schedules：Plan production and import arrangements well ahead of the November 2026 Class C compliance deadline. Control import volumes before the cutoff to avoid excess non-compliant stock. Roll out updated labeling specifications to suppliers and contract manufacturers to guarantee full UDI compliance for all new batches.

Prepare for Upcoming Regulatory Deadlines：Class B devices will face mandatory UDI enforcement in 2028. Enterprises are recommended to embed UDI planning into long-term product lifecycle management, integrating UDI design at the new product development stage to achieve unified global compliance.

五、Conclusion

As a benchmark medical market in Southeast Asia, Singapore’s UDI system balances rigorous supervision and manufacturer-friendly policies. For medical device companies with global expansion plans, leveraging Singapore as a regional hub with a single UDI code covering EU, US and Southeast Asian markets is the optimal solution to boost compliance efficiency and cut cross-border operational costs.For further inquiries, please consult Wiselink.

Previous：无 Next：What Is the Difference Between MDEL and MDL? A Complete Guide to Canadian Registration Requirements

Fill Form

Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.